›› 2013, Vol. 33 ›› Issue (6): 759-.doi: 10.3969/j.issn.1674-8115.2013.06.012

• Original article (Basic research) • Previous Articles     Next Articles

Detection of transfection efficiency of hepatocyte-targeting Gal-Bu in rat liver cells

WANG Yu-qiang1, SHENG Jing2, CHEN Shu-yan1, SU Jing3   

  1. 1.Department of Geriatrics, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, China; 2.Department of Geriatrics, the Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200011, China; 3.School of Pharmacy, Shanghai Jiaotong University, Shanghai 200240, China
  • Online:2013-06-28 Published:2013-06-28
  • Supported by:

    National Natural Science Foundation of China, 81001416, 30973152, 81270205; Shanghai Science and Technology Committee Foundation, 10JC1408902


Objective To evaluate the transfection efficiency of hepatocyte-targeting galactosylated polyethylenimine derivative Gal-Bu in rat liver cells (BRL-3A). Methods Gal-Bu was synthesized through chemical modification of PEI-Bu with galactose residue. The pDNA condensation ability of the polymer was evaluated by agarose gel electrophoresis, MTT assay was employed to detect the cytotoxicity of the polymer in BRL-3A cells, luciferase plasmid was used as the reporter gene to determine the transfection efficiency of Gal-Bu in BRL-3A cells, and competition assay of galactose was performed to investigate the hepatocyte-targeting property of Gal-Bu. Results Gel retardation assay showed complete condensation of pDNA at weight ratio >15. At concentrations ranging from 5 to 100 μg/mL, cytotoxicity of Gal-Bu and PEI 25 000 increased with the concentrations. Gal-Bu exhibited lower cytotoxicity than PEI 25 000 at the same concentration (P<0.01). The polymer performed the highest transfection efficiency at weight ratio of 50, which was 5.6 times of PEI 25 000 (P<0.01) and was close to Lipofectamine 2000. Competition assay of galactose revealed that the transfection efficiency of Gal-Bu was significantly decreased in the presence of 100 mmol/L galactose (P<0.01), whereas this phenomenon was not observed on the transfection efficiency of PEI-Bu (P>0.05). Conclusion Gal-Bu is a non-viral hepatocyte-targeting gene carrier with lower cytotoxicity and enhanced transfection efficiency, which would be a promising candidate in hepatocyte-targeting gene therapy.

Key words: hepatocyte-targeting, non-viral gene carrier, galactose, transfection efficiency, cytotoxicity